Synthesis and biological evaluation of some 1,3,4-oxadiazole derivatives

被引:137
|
作者
Manjunatha, K. [1 ]
Poojary, Boja [1 ]
Lobo, Prajwal L. [1 ]
Fernandes, Jennifer [2 ]
Kumari, N. Suchetha [3 ]
机构
[1] Mangalore Univ, Dept Chem, Mangalagangothri 574199, Karnataka, India
[2] NGSM Coll Pharm, Dept Pharmachem, Derlakatte 574160, Karnataka, India
[3] KS Hegde Med Acad, Dept Biochem, Derlakatte 574162, Karnataka, India
关键词
1,3,4-Oxadiazol-2-thiones; Ibuprofen; 4-Methylthiophenyl; Antimicrobial activity; Anti-inflammatory activity; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ANTIMICROBIAL ACTIVITIES; CIPROFLOXACIN;
D O I
10.1016/j.ejmech.2010.08.039
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The acid hydrazides (2) derived from ibuprofen and 4-methylthiophenyl acetic acids have been subjected to cyclization with carbon disulphide under basic conditions to yield 1,3,4-oxadiazol-2-thiones (3) which on aminomethylation with formaldehyde and secondary amines afforded a series of Mannich bases (4 and 5). Purity of the compounds has been confirmed by TLC. Structures of these compounds were established on the basis of elemental analyses and spectral studies. The newly synthesized compounds were evaluated for their anti-inflammatory, analgesic, ulcerogenic and antimicrobial activities. (C) 2010 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:5225 / 5233
页数:9
相关论文
共 50 条
  • [21] Synthesis, Characterization and Biological Activity Studies of 1,3,4-Oxadiazole Analogs
    Bhat, K., I
    Sufeera, K.
    Kumar, Chaitanya Sunil P.
    JOURNAL OF YOUNG PHARMACISTS, 2011, 3 (04) : 310 - 314
  • [22] Synthesis and Evaluation of Biological Activity of Homodrimane Sesquiterpenoids Bearing 1,3,4-Oxadiazole or 1,3,4-Thiadiazole Units
    Lungu, Lidia
    Ciocarlan, Alexandru
    Smigon, Crina
    Ozer, Ilker
    Shova, Sergiu
    Gutu, Iacob
    Vornicu, Nicoleta
    Mangalagiu, Ionel
    D'Ambrosio, Michele
    Aricu, Aculina
    CHEMISTRY OF HETEROCYCLIC COMPOUNDS, 2020, 56 (05) : 578 - 585
  • [23] Synthesis and Biological Evaluation of some Novel 2-Mercaptobenzothiazoles Carrying 1,3,4-Oxadiazole, 1,3,4-Thiadiazole and 1,2,4-Triazole Moieties
    Azam, M. Afzal
    Suresh, Bhojraj
    Kalsi, Sandip S.
    Antony, A. Shinesh
    SOUTH AFRICAN JOURNAL OF CHEMISTRY-SUID-AFRIKAANSE TYDSKRIF VIR CHEMIE, 2010, 63 : 114 - 122
  • [24] Synthesis and evaluation of novel 1,3,4-oxadiazole derivatives of marine bromopyrrole alkaloids as antimicrobial agent
    Rane, Rajesh A.
    Gutte, Shweta D.
    Sahu, Niteshkumar U.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (20) : 6429 - 6432
  • [25] Synthesis and biological activity of 5-substituted-2-amino-1,3,4-oxadiazole derivatives
    Kumar, Sanjeev
    TURKISH JOURNAL OF CHEMISTRY, 2011, 35 (01) : 99 - 108
  • [26] Synthesis and biological evaluation of 2,5-disubstituted 1,3,4-oxadiazole derivatives with both COX and LOX inhibitory activity
    Akhter, Mymoona
    Akhter, Nayeema
    Alam, M. M.
    Zaman, M. S.
    Saha, Rikta
    Kumar, A.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2011, 26 (06) : 767 - 776
  • [27] CHLORAMINE-T MEDIATED SYNTHESIS OF NOVEL 1,3,4-OXADIAZOLE DERIVATIVES
    Dhanya, K.
    Revanasiddappa, B. C.
    HETEROCYCLIC LETTERS, 2023, 13 (01): : 137 - 142
  • [28] Design, synthesis, and biological evaluation of novel fluorinated pyrazole encompassing pyridyl 1,3,4-oxadiazole motifs
    Desai, Nisheeth C.
    Kotadiya, Ghanshyam M.
    Trivedi, Amit R.
    Khedkar, Vijay M.
    Jha, Prakash C.
    MEDICINAL CHEMISTRY RESEARCH, 2016, 25 (11) : 2698 - 2717
  • [29] Design, synthesis, and biological evaluation of novel fluorinated pyrazole encompassing pyridyl 1,3,4-oxadiazole motifs
    Nisheeth C. Desai
    Ghanshyam M. Kotadiya
    Amit R. Trivedi
    Vijay M. Khedkar
    Prakash C. Jha
    Medicinal Chemistry Research, 2016, 25 : 2698 - 2717
  • [30] Hydrazides: An Important Tool for the Synthesis of 1,3,4-Oxadiazole
    Tripathi, Shrishti
    Kumar, Rajnish
    Mazumder, Avijit
    Kukreti, Neelima
    Kumar, Arvind
    Singh, Gurvinder
    CURRENT ORGANIC CHEMISTRY, 2025, 29 (08) : 658 - 668